EC Number   |
Title |
Organism |
|---|
   2.7.1.153 | Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway |
Homo sapiens |
| 2.7.1.153 | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum A brief report |
Homo sapiens |
| 2.7.1.153 | Role of phosphatidylinositol-4,5-bisphosphate 3-kinase signaling in vesicular trafficking |
Homo sapiens |
| 2.7.1.153 | The role of class IA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunits in glioblastoma |
Homo sapiens |
| 2.7.1.153 | A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability |
Homo sapiens |
| 2.7.1.153 | A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability |
Mus musculus |
| 2.7.1.153 | A yeast-based in vivo bioassay to screen for class I phosphatidylinositol 3-kinase specific inhibitors |
Homo sapiens |
| 2.7.1.153 | Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation |
Homo sapiens |
| 2.7.1.153 | Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation |
Mus musculus |
| 2.7.1.153 | Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin |
Mus musculus |
